USPSTF Guidelines UPDATED Exam
Questions and CORRECT Answers
Abdominal Aortic Aneurysm: Screening: men aged 65 to 75 years who have ever smoked -
CORRECT ANSWER - The USPSTF recommends 1-time screening for abdominal aortic
aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked. B
December 2019 *
Anxiety Disorders in Adults: Screening: adults 64 years or younger, including pregnant and
postpartum persons - CORRECT ANSWER - The USPSTF recommends screening for
anxiety disorders in adults, including pregnant and postpartum persons. B June 2023
Anxiety in Children and Adolescents: Screening: children and adolescents aged 8 to 18 years -
CORRECT ANSWER - The USPSTF recommends screening for anxiety in children and
adolescents aged 8 to 18 years. B October 2022
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive
Medication: pregnant persons at high risk for preeclampsia - CORRECT ANSWER - The
USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12
weeks of gestation in persons who are at high risk for preeclampsia. See the Practice
Considerations section for information on high risk and aspirin dose. B September 2021 *
Asymptomatic Bacteriuria in Adults: Screening: pregnant persons - CORRECT
ANSWER - The USPSTF recommends screening for asymptomatic bacteriuria using urine
culture in pregnant persons. B September 2019 *
BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing: women with
a personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry
associated with brca1/2 gene mutation - CORRECT ANSWER - The USPSTF
recommends that primary care clinicians assess women with a personal or family history of
breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer
susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk
assessment tool. Women with a positive result on the risk assessment tool should receive genetic
counseling and, if indicated after counseling, genetic testing. B August 2019 *
, Breast Cancer: Medication Use to Reduce Risk: women at increased risk for breast cancer aged
35 years or older - CORRECT ANSWER - The USPSTF recommends that clinicians offer
to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to
women who are at increased risk for breast cancer and at low risk for adverse medication effects.
B September 2019 *
Breast Cancer: Screening: women aged 40 to 74 years - CORRECT ANSWER - The
USPSTF recommends biennial screening mammography for women aged 40 to 74 years. † B
April 2024 *
Breastfeeding: Primary Care Behavioral Counseling Interventions: pregnant and postpartum
women - CORRECT ANSWER - The USPSTF recommends providing interventions or
referrals, during pregnancy and after birth, to support breastfeeding. B April 2025 *
Cervical Cancer: Screening: women aged 21 to 65 years - CORRECT ANSWER - The
USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in
women aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommends
screening every 3 years with cervical cytology alone, every 5 years with high-risk human
papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with
cytology (cotesting). See the Clinical Considerations section for the relative benefits and harms
of alternative screening strategies for women 21 years or older. A August 2018 *
Chlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons -
CORRECT ANSWER - The USPSTF recommends screening for gonorrhea in all sexually
active women 24 years or younger and in women 25 years or older who are at increased risk for
infection. B September 2021 *
Chlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons -
CORRECT ANSWER - The USPSTF recommends screening for chlamydia in all sexually
active women 24 years or younger and in women 25 years or older who are at increased risk for
infection. B September 2021 *
Colorectal Cancer: Screening: adults aged 45 to 49 years - CORRECT ANSWER - The
USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. See the
"Practice Considerations" section and Table 1 for details about screening strategies. B May 2021
*
Questions and CORRECT Answers
Abdominal Aortic Aneurysm: Screening: men aged 65 to 75 years who have ever smoked -
CORRECT ANSWER - The USPSTF recommends 1-time screening for abdominal aortic
aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked. B
December 2019 *
Anxiety Disorders in Adults: Screening: adults 64 years or younger, including pregnant and
postpartum persons - CORRECT ANSWER - The USPSTF recommends screening for
anxiety disorders in adults, including pregnant and postpartum persons. B June 2023
Anxiety in Children and Adolescents: Screening: children and adolescents aged 8 to 18 years -
CORRECT ANSWER - The USPSTF recommends screening for anxiety in children and
adolescents aged 8 to 18 years. B October 2022
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive
Medication: pregnant persons at high risk for preeclampsia - CORRECT ANSWER - The
USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12
weeks of gestation in persons who are at high risk for preeclampsia. See the Practice
Considerations section for information on high risk and aspirin dose. B September 2021 *
Asymptomatic Bacteriuria in Adults: Screening: pregnant persons - CORRECT
ANSWER - The USPSTF recommends screening for asymptomatic bacteriuria using urine
culture in pregnant persons. B September 2019 *
BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing: women with
a personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry
associated with brca1/2 gene mutation - CORRECT ANSWER - The USPSTF
recommends that primary care clinicians assess women with a personal or family history of
breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer
susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk
assessment tool. Women with a positive result on the risk assessment tool should receive genetic
counseling and, if indicated after counseling, genetic testing. B August 2019 *
, Breast Cancer: Medication Use to Reduce Risk: women at increased risk for breast cancer aged
35 years or older - CORRECT ANSWER - The USPSTF recommends that clinicians offer
to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to
women who are at increased risk for breast cancer and at low risk for adverse medication effects.
B September 2019 *
Breast Cancer: Screening: women aged 40 to 74 years - CORRECT ANSWER - The
USPSTF recommends biennial screening mammography for women aged 40 to 74 years. † B
April 2024 *
Breastfeeding: Primary Care Behavioral Counseling Interventions: pregnant and postpartum
women - CORRECT ANSWER - The USPSTF recommends providing interventions or
referrals, during pregnancy and after birth, to support breastfeeding. B April 2025 *
Cervical Cancer: Screening: women aged 21 to 65 years - CORRECT ANSWER - The
USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in
women aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommends
screening every 3 years with cervical cytology alone, every 5 years with high-risk human
papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with
cytology (cotesting). See the Clinical Considerations section for the relative benefits and harms
of alternative screening strategies for women 21 years or older. A August 2018 *
Chlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons -
CORRECT ANSWER - The USPSTF recommends screening for gonorrhea in all sexually
active women 24 years or younger and in women 25 years or older who are at increased risk for
infection. B September 2021 *
Chlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons -
CORRECT ANSWER - The USPSTF recommends screening for chlamydia in all sexually
active women 24 years or younger and in women 25 years or older who are at increased risk for
infection. B September 2021 *
Colorectal Cancer: Screening: adults aged 45 to 49 years - CORRECT ANSWER - The
USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. See the
"Practice Considerations" section and Table 1 for details about screening strategies. B May 2021
*
